Les Stewart
Directeur des opérations chez Agilvax, Inc.
Profil
Les Stewart is the founder of SolaranRx, Inc. which was founded in 2014.
He held the title of President & Chief Executive Officer from 2014 to 2015.
Currently, he is the Chief Operating Officer at Agilvax, Inc. Mr. Stewart has an MBA from Carnegie Mellon University and an undergraduate degree from Kettering University.
Postes actifs de Les Stewart
| Sociétés | Poste | Début |
|---|---|---|
Agilvax, Inc.
 Agilvax, Inc. BiotechnologyHealth Technology Agilvax, Inc. discovers and develops immunotherapies to combat cancer and targeted vaccines against infectious diseases. It optimizes lead immunotherapy candidates through an extensive in vitro and in vivo testing process to ensure clinical efficacy. The company was founded in 2011 and is headquartered in Albuquerque, NM. | Directeur des opérations | - |
Anciens postes connus de Les Stewart
| Sociétés | Poste | Fin |
|---|---|---|
SolaranRx, Inc.
 SolaranRx, Inc. BiotechnologyHealth Technology SolaranRx, Inc. develops therapies and companion imaging agents for the treatment of metastatic melanoma. It offers radiolabeled peptide that specifically binds to melanocortin-1 receptors on the surface of melanoma cells to identify patients suitable for treatment and to deliver targeted radiation potentially destroying receptor expressing tumors. The company was founded by Les Stewart and Stuart Rose in 2014 and is headquartered in Albuquerque, NM. | Fondateur | - |
Formation de Les Stewart
| Carnegie Mellon University | Masters Business Admin |
| Kettering University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Agilvax, Inc.
Agilvax, Inc. BiotechnologyHealth Technology Agilvax, Inc. discovers and develops immunotherapies to combat cancer and targeted vaccines against infectious diseases. It optimizes lead immunotherapy candidates through an extensive in vitro and in vivo testing process to ensure clinical efficacy. The company was founded in 2011 and is headquartered in Albuquerque, NM. | Health Technology |
SolaranRx, Inc.
SolaranRx, Inc. BiotechnologyHealth Technology SolaranRx, Inc. develops therapies and companion imaging agents for the treatment of metastatic melanoma. It offers radiolabeled peptide that specifically binds to melanocortin-1 receptors on the surface of melanoma cells to identify patients suitable for treatment and to deliver targeted radiation potentially destroying receptor expressing tumors. The company was founded by Les Stewart and Stuart Rose in 2014 and is headquartered in Albuquerque, NM. | Health Technology |